Teens Show Support
"Kaitlyn Purvis, 17, has a PICC line dangling from the underside of her left arm. It's like the one her friend Shayna (Shay) Gavin, 17, has in the same spot on her arm.
Shayna was recently diagnosed with both Hodgkin's lymphoma and diffuse large b cell lymphoma.
She is one of several young women facing the unsavoury prospect of cancer treatment who attends St. Michael Secondary School.
When her friend Brittany Taylor was diagnosed with Hodgkin's lymphoma last year she made green bracelets to sell at the school to support Brittany.
Less than a year later she's starting chemotherapy herself.
"We're still all numb here and a little in shock," said Shay's aunt Terri McLeod.
To show her support for Shay, Kaitlyn wrote her a song and posted it on YouTube where it had more than 1,200 views by Saturday and on ITunes. "Shayna's Song" costs 99 cents to download from ITunes and all the proceeds go to the Gavin family or to cancer research."
Read more: http://www.stratfordbeaconherald.com/ArticleDisplay.aspx?e=2814226
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
